Inoue T, Watanabe N
Nihon Naibunpi Gakkai Zasshi. 1986 Jan 20;62(1):45-59. doi: 10.1507/endocrine1927.62.1_45.
Determination of plasma IGF-I concentrations is not easily accessible to clinical use at present because of extremely limited supply of purified natural IGF-I essential for its assay system. Thus, an alternative method has recently been introduced by the development of a specific radioimmunoassay (RIA) for IGF-I (26-46). We examined the specificity and sensitivity of this assay system, and then investigated the changes in plasma concentrations of IGF-I in normal children, adults and in patients with various endocrine and metabolic diseases. Each plasma sample was subjected to acid-ethanol treatment before assay to separate IGF-I from its binding protein. The recovery rate of known amount of IGF-I (26-46) added to untreated plasma sample was more than 90%. The coefficients of variation of intra- and interassay were 9.0% and 13.6%, respectively. This assay system was able to detect IGF-I as low as 10 pg/tube. When plasma sample of a patient with active acromegaly was applied to Sephadex G-75 column, immunoreactive IGF-I was eluted at the position of 7,000 molecular weight. An inhibition curve of plasma extract from an acromegalic patient was parallel to that of IGF-I (26-46), indicating that the RIA could detect IGF-I. There was no remarkable difference between IGF-I values of plasma and serum from the same individual. The value of IGF-I concentration of cord plasma was considerably low (144 +/- 6.7 pg/ml, M +/- SEM) as compared with that of sera of 49 normal children aged 7-12 12 years (320 +/- 14.3 pg/ml). The highest value (460 +/- 54 pg/ml) was attained at the age of 13 years, followed by gradual decrease toward adult age. Plasma IGF-I concentration of normal adults between 20 and 69 years of age was 290 +/- 10 pg/ml. When plasma IGF-I values of adult males and females were separately plotted against age group of each decade, the value declined gradually with age in males while in females there was a remarkable increase in plasma IGF-I concentration at 4th and 5th decades, suggesting the effect of hormonal change at menopause on plasma IGF-I levels. There was a good correlation between disorders of GH secretion and plasma IGF-I concentrations. In 10 cases of active acromegaly the level was 506 +/- 67 pg/ml (285-970 pg/ml). On the other hand in 20 patients with pituitary dwarfism it was only 180 +/- 15 pg/ml.(ABSTRACT TRUNCATED AT 400 WORDS)
目前,由于用于检测系统的纯化天然胰岛素样生长因子-I(IGF-I)供应极其有限,血浆IGF-I浓度的测定在临床应用中并不容易实现。因此,最近通过开发一种针对IGF-I的特异性放射免疫分析(RIA)方法引入了一种替代方法(26 - 46)。我们检测了该检测系统的特异性和敏感性,然后研究了正常儿童、成人以及各种内分泌和代谢疾病患者血浆中IGF-I浓度的变化。在检测前,对每个血浆样本进行酸乙醇处理,以将IGF-I与其结合蛋白分离。添加到未处理血浆样本中的已知量IGF-I(26 - 46)的回收率超过90%。批内和批间变异系数分别为9.0%和13.6%。该检测系统能够检测低至10 pg/管的IGF-I。将一名活动性肢端肥大症患者的血浆样本应用于Sephadex G - 75柱时,免疫反应性IGF-I在分子量7000的位置洗脱。肢端肥大症患者血浆提取物的抑制曲线与IGF-I(26 - 46)的抑制曲线平行,表明该RIA能够检测IGF-I。同一个体的血浆和血清IGF-I值之间没有显著差异。与49名7 - 12岁正常儿童的血清(320±14.3 pg/ml)相比,脐血血浆IGF-I浓度相当低(144±6.7 pg/ml,均值±标准误)。在13岁时达到最高值(460±54 pg/ml),随后随着年龄增长逐渐下降至成年水平。20至69岁正常成年人的血浆IGF-I浓度为290±10 pg/ml。当分别绘制成年男性和女性的血浆IGF-I值与每个十年年龄组的关系图时,男性的值随年龄逐渐下降,而女性在第四和第五个十年血浆IGF-I浓度显著增加,表明绝经时激素变化对血浆IGF-I水平的影响。生长激素(GH)分泌紊乱与血浆IGF-I浓度之间存在良好的相关性。10例活动性肢端肥大症患者的水平为506±67 pg/ml(285 - 970 pg/ml)。另一方面,20例垂体性侏儒症患者的水平仅为180±15 pg/ml。(摘要截断于400字)